Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

7 Biggest Lithium-mining Companies in 2024

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Top 10 Oil-producing Countries (Updated 2024)

Where Does Tesla Get its Lithium? (Updated 2024)

How to Invest in OpenAI's ChatGPT (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

Hydrogen Stocks: 9 Biggest Companies in 2024

Top 10 Countries for Natural Gas Production (Updated 2024)

Trending Press Releases

SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout

Altech – CERENERGY® First 60 KWh Prototype Online and Achieving Great Results

In Search of Alternative Financing for Critical Minerals Projects

Glencore Loan Facility Closed, Offtakes Executed

Vertex Acquires Drill Rig to Advance Exploration, at the High-Grade Reward Gold Mine, Below the Existing Resource

More Press Releases
Trending Companies

Saga Metals

SAGA:CA

Albemarle Corporation

ALB

Sociedad Quimica y Minera S.A. (SQM)

SQM:NYE

Black Swan Graphene

SWAN:CC
More Companies
Trending Reports

2024 Lithium Market Outlook

Nickel Investor Report

Silver Price Forecast - What Happened And Where Do We Go From Here?

2024 Gold Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Impel NeuroPharma Inc.

NASDAQ:IMPL
Press Releases

Impel NeuroPharma Inc is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. Its pipeline of proprietary product candidates includes INP107 for the treatment of OFF episodes in Parkinson's Disease.

Interactive Chart

×